Abstract
Objectives
S100A8 is highly expressed in several inflammatory and oncological conditions. To address the current lack of a reliable and sensitive detection method for S100A8, we generated a monoclonal antibody with a high binding affinity to human S100A8 to enable early disease diagnosis.
Results
A soluble recombinant S100A8 protein with a high yield and purity was produced using Escherichia coli. Next, mice were immunized with recombinant S100A8 to obtain anti-human S100A8 monoclonal antibodies using hybridoma technology. Lastly, the high binding activity of the antibody was confirmed and its sequence was identified.
Conclusions
This method, including the production of antigens and antibodies, will be useful for the generation of hybridoma cell lines that produce anti-S100A8 monoclonal antibodies. Moreover, the sequence information of the antibody can be used to develop a recombinant antibody for use in various research and clinical applications.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Armbruster DA, Pry T (2008) Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 29(Suppl 1):S49-52
Berthier S, Nguyen MVC, Baillet A, Horgraindleur M, Packet M, Polack B, Morel F (2012) Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation. PLoS ONE 7:e40277
Burmeister G, Gallacchi G (1995) A selective method for determining MRP8 and MRP14 homocomplexes and heterocomplexes by sandwich ELISA for the discrimination of active and non-active osteoarthritis from rheumatoid arthritis in sera and synovial fluids. Inflammopharmacology 3:221–230
Crowe LAN, McLean M, Kitson SM, Melchor EG, Patommel K, Cao HM, Reilly JH, Leach WJ, Rooney BP, Spencer SJ, Mullen M, Chambers M, Murrell GAC, McInnes IB, Akbar M, Millar NL (2019) S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy. Sci Rep 9:1463
Dallmeier K, Neyts J (2013) Simple and inexpensive three-step rapid amplification of cDNA 5’ ends using 5’ phosphorylated primers. Anal Biochem 434:1–3
Futami J, Atago Y, Azuma A, Putranto EW, Kinoshita R, Murata H, Sakaguchi M (2016) An efficient method for the preparation of preferentially heterodimerized recombinant S100A8/A9 coexpressed in Escherichia coli. Biochem Biophys Rep 6:94–100
Gao Y, Huang X, Zhu Y, Lv Z (2018) A brief review of monoclonal antibody technology and its representative applications in immunoassays. J Immunoassay Immunochem 39:351–364
Gebhardt C, Nemeth J, Angel P, Hess J (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72:1622–1631
Gong H, Su W-J, Cao Z-Y, Lian Y-J, Peng W, Liu Y-Z, Zhang Y, Liu L-L, Wu R, Wang B, Zhang T, Wang Y-X, Jiang C-L (2018) Hippocampal Mrp8/14 signaling plays a critical role in the manifestation of depressive-like behaviors in mice. J Neuroinflammation 15:252
Ishikawa K, Nakagawa A, Tanaka I, Suzuki M, Nishihira J (2000) The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr 56:559–566
Johnson N, Ebersole JL, Kryscio RJ, Danaher RJ, Dawson D 3rd, Al-Sabbagh M, Miller CS (2016) Rapid assessment of salivary MMP-8 and periodontal disease using lateral flow immunoassay. Oral Dis 22:681–687
Kido J, Bando M, Hiroshima Y, Iwasaka H, Yamada K, Ohgami N, Nambu T, Kataoka M, Yamamoto T, Shinohara Y, Sagawa I, Nagata T (2012) Analysis of proteins in human gingival crevicular fluid by mass spectrometry. J Periodontal Res 47:488–499
Kim HD, Lee CS, Cho HJ, Jeon S, Choi YN, Kim S, Kim D, Jin Lee H, Vu H, Jeong HJ, Kim B (2020) Diagnostic ability of salivary matrix metalloproteinase-9 lateral flow test point-of-care test for periodontitis. J Clin Periodontol 47:1354–1361
Kim EJ, Im GM, Lee CS, Kim YG, Ko BJ, Jeong HJ, Kim BG (2021) Generation of monoclonal antibodies for sensitive detection of pro-inflammatory protein S100A9. Appl Sci 11:4659
Kim JW, Jung JY, Lee SW, Baek WY, Kim HA, Suh CH (2022) S100A8 in serum, urine, and saliva as a potential biomarker for systemic lupus erythematosus. Front Immunol 13:886209
Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M (2019) Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis. Int J Cancer 145:569–575
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
Kojima T, Andersen E, Sanchez JC, Wilkins MR, Hochstrasser DF, Pralong WF, Cimasoni G (2000) human gingival crevicular fluid contains MRP8 (S100A8) and MRP14 (S100A9), two calcium-binding proteins of the S100 family. J Dent Res 79:740–747
Lagasse E, Clerc RG (1988) Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 8:2402–2410
Loser K, Vogl T, Voskort M, Lueken A, Kupas V, Nacken W, Klenner L, Kuhn A, Foell D, Sorokin L, Luger TA, Roth J, Beissert S (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16:713–717
Lundy FT, Chalk R, Lamey PJ, Shaw C, Linden GJ (2001) Quantitative analysis of MRP-8 in gingival crevicular fluid in periodontal health and disease using microbore HPLC. J Clin Periodontol 28:1172–1177
Ngo LH, Veith PD, Chen YY, Chen D, Darby IB, Reynolds EC (2010) Mass spectrometric analyses of peptides and proteins in human gingival crevicular fluid. J Proteome Res 9:1683–1693
Pruenster M, Vogl T, Roth J, Sperandio M (2016) S100A8/A9: From basic science to clinical application. Pharmacol Ther 167:120–131
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in escherichia coli: advances and challenges. Front Microbiol 5:172
Rosano GL, Morales ES, Ceccarelli EA (2019) New tools for recombinant protein production in Escherichia coli: A 5-year update. Protein Sci 28:1412–1422
Sakaguchi M, Toyooka S, Tomida S, Shien K, Sato H, Kinoshita R, Futami J, Araki K, Okazaki M, Kondo E, Inoue Y and Yamauchi A (2019) Anti-S100A8/A9 antibody and use thereof, WO21019/208290.
Sandomenico A, Sivaccumar JP, Ruvo M (2020) Evolution of escherichia coli expression system in producing antibody recombinant fragments. Int J Mol Sci 21:6324
Tardif MR, Chapeton-Montes JA, Posvandzic A, Pagé N, Gilbert C, Tessier PA (2015) Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux. J Immunol Res 2015:296149
van Lent PLEM, Grevers LC, Blom AB, Arntz OJ, van de Loo FAJ, van der Kraan P, Abdollahi-Roodsaz S, Srikrishna G, Freeze H, Sloetjes A, Nacken W, Vogl T, Roth J, van den Berg WB (2008) Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 58:3776–3787
Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13:1042–1049
Vogl T, Gharibyan AL, Morozova-Roche LA (2012) Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci 13:2893–2917
Vogl T, Eisenblätter M, Völler T, Zenker S, Hermann S, van Lent P, Faust A, Geyer C, Petersen B, Roebrock K, Schäfers M, Bremer C, Roth J (2014a) Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat Commun 5:4593
Vogl T, Eisenblatter M, Voller T, Zenker S, Hermann S, van Lent P, Faust A, Geyer C, Petersen B, Roebrock K, Schafers M, Bremer C, Roth J (2014b) Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat Commun 5:4593
Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J (2018) S100A8/A9 in Inflammation. Front Immunol 9:1298
Funding
This work was supported by Korea Forest Service (Korea Forestry Promotion Institute) R&D Program for Forest Science Technology (2022417A00-2223-AA02), National Research Foundation of Korea (NRF) grants funded by the Korean government (NRF-2017M3A9B6062989, NRF-2020R1I1A307411712), Korea Medical Device Development Fund (KMDF_PR_20200901_0073) and 2022 Hongik University Research Frontier.
Author information
Authors and Affiliations
Contributions
Conceptualization: JPK and HJJ, methodology and analysis: JPK, HY, and EJK, investigation: JPK, HY, EJK, YGK, CSL, BJK, BGK. and HJJ, writing—original draft preparation: JPK and HJJ, writing—review and editing: YGK, CSL, BJK, BGK and HJJ, supervision: HJJ All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kim, JP., Yun, H., Kim, EJ. et al. Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology. Biotechnol Lett 45, 589–600 (2023). https://doi.org/10.1007/s10529-023-03364-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-023-03364-0